Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Inderjit Gill, MD, is a Staff cardiothoracic surgeon with the Cleveland Clinic's Heart Center at Cleveland Clinic's main campus, and serves as the Director of the Departments of Thoracic and Cardiovascular Surgery at Fairview Hospital and at the MetroHealth Medical Center. His specialty interests include the surgical treatment of adult acquired heart disease, minimally invasive surgery, off-pump coronary bypass surgery, surgery of the aorta and robotic cardiac surgery.
Dr. Gill received his medical degree from Christian Medical College and Brown Memorial Hospital in Punjab, India. He completed his surgical residency in the United Kingdom at Colchester General Hospital, which is an affiliate of the St. Thomas Hospital at the University of London. He was awarded a Cleveland Clinic Fellowship in cardiovascular surgery in the Department of Cardiothoracic Surgery and then completed an approved residency in cardiothoracic surgery from the University of Ottawa Heart Institute where he was then given a staff appointment and was a tenured assistant professor. Dr. Gill pioneered the technique of minimally invasive cardiac surgery in Canada. He joined Cleveland Clinic as an attending staff cardiothoracic surgeon in 1999.
Dr. Gill has been a principal site investigator in a number of clinical research trials including the POEM trial ,which was the first multicenter, randomized trial comparing off-pump surgery with conventional bypass, and a multicenter FDA approved trial to use Robotic assistance for coronary anastomosis. The first coronary anastomosis using the ZeusTM system in Ohio was completed successfully in August 2001.
Dr. Gill serves as an editorial reviewer for professional journals, such as The Annals of Thoracic Surgery, Circulation, The Canadian Journal of Cardiology, and The Journal of Thoracic and Cardiovascular Surgery. He has presented and published extensively on topics related to minimally invasive coronary surgery and on delayed operative intervention in the management of traumatic descending thoracic aortic rupture in major international meetings and journals.
Dr. Gill is a charter member of the International Society of Minimally Invasive Cardiac Surgery, the Canadian Society of Cardiac Surgeons, the Society of Critical Care Medicine, the Canadian Cardiovascular Society, the Society of Thoracic Surgeons and the Indian Association of Cardiothoracic Surgeons.
Dr. Gill is a Fellow of the Royal College of Surgeons of Ireland and a Fellow of the Royal College of Surgeons of England. He holds a specialist certificate in cardiothoracic surgery from the Royal College of Physicians and Surgeons of Canada. Dr. Gill holds medical licensures in Ohio and Ontario. He is a Fellow of the American College of Surgeons.
Cardiac surgery, aorta surgery, heart valve surgery, bypass surgery, minimally invasive heart surgery, off pump heart surgery, pericardiectomy, robotically assisted heart surgery, atrial septal defect closure, coronary artery reoperation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/29/2015, Dr. Gill has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.